285 related articles for article (PubMed ID: 3124997)
1. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.
Hiromatsu Y; Fukazawa H; How J; Wall JR
Clin Exp Immunol; 1987 Dec; 70(3):593-603. PubMed ID: 3124997
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of immune damage in Graves' ophthalmopathy.
Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
[TBL] [Abstract][Full Text] [Related]
3. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
4. Failure to detect complement-mediated antibody-dependent cytotoxicity against human orbital tissue cells in the serum of patients with thyroid-associated ophthalmopathy.
Dillon J; Zhang ZG; Hiromatsu N; Bernard M; Salvi M; Wall JR
Autoimmunity; 1989; 5(1-2):125-32. PubMed ID: 2519012
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
6. Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy.
Heufelder AE; Smith TJ; Gorman CA; Bahn RS
J Clin Endocrinol Metab; 1991 Aug; 73(2):307-13. PubMed ID: 1906894
[TBL] [Abstract][Full Text] [Related]
7. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunoglobulin G from patients with Graves' ophthalmopathy and interferon gamma in intercellular adhesion molecule-1 and human leucocyte antigen-DR expression in human retroocular fibroblasts.
Li Y; Chen L; Teng W; Shan Z; Li Z
Chin Med J (Engl); 2000 Aug; 113(8):752-5. PubMed ID: 11776063
[TBL] [Abstract][Full Text] [Related]
9. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy.
Hiromatsu Y; Fukazawa H; Guinard F; Salvi M; How J; Wall JR
J Clin Endocrinol Metab; 1988 Sep; 67(3):565-70. PubMed ID: 3410941
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy.
Heufelder AE; Bahn RS
Clin Exp Immunol; 1993 Mar; 91(3):381-9. PubMed ID: 7680294
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.
Tandon N; Yan SL; Arnold K; Metcalfe RA; Weetman AP
Clin Endocrinol (Oxf); 1994 May; 40(5):629-39. PubMed ID: 8013144
[TBL] [Abstract][Full Text] [Related]
12. New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirm their significance in thyroid-associated ophthalmopathy.
Barsouk A; Wengrowicz S; Scalise D; Stolarski C; Nebes V; Sato M; Wall JR
Thyroid; 1995 Jun; 5(3):195-200. PubMed ID: 7580267
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic mechanisms in autoimmune thyroid disorders and thyroid-associated ophthalmopathy.
Hiromatsu Y; Fukazawa H; Wall JR
Endocrinol Metab Clin North Am; 1987 Jun; 16(2):269-86. PubMed ID: 3319585
[TBL] [Abstract][Full Text] [Related]
14. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
[TBL] [Abstract][Full Text] [Related]
15. Immunologically mediated cytotoxicity against human eye muscle and thyroid cells in euthyroid and thyrotoxic Graves' ophthalmopathy.
Medeiros-Neto G; Zhang ZG; Lima N; Iacona A; Liberman A; Salvi M; Wall JR
Autoimmunity; 1991; 9(4):293-300. PubMed ID: 1954309
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
Sung MW; Johnson JT; Van Dongen G; Whiteside TL
Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
[TBL] [Abstract][Full Text] [Related]
17. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts.
Heufelder AE; Bahn RS
Eur J Clin Invest; 1992 Aug; 22(8):529-37. PubMed ID: 1358619
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
Heufelder AE
Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
[TBL] [Abstract][Full Text] [Related]
20. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
